Mitomycin C as an adjunct in the treatment of localised ocular surface squamous neoplasia

British Journal of Ophthalmology

Volumn 88, Issue 1, 2004, Pages 17-18

  Chen, C ^a   Louis, D ^a   Dodd, T ^b   Muecke, James ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C;

ADULT; AGED; ARTICLE; CATARACT; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA ULCER; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; EXCISION; EYE TOXICITY; EYE TUMOR; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; MALE; OCULAR SURFACE SQUAMOUS NEOPLASM; PRIORITY JOURNAL; RETINA PIGMENT EPITHELIOPATHY; SIDE EFFECT; TREATMENT WITHDRAWAL; TUMOR RECURRENCE; UVEITIS;

AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; EYE NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES;

EID: 0347755428     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.88.1.17     Document Type: Article

References (16)

1. Lee GA, Hirst LW. Incidence of ocular surface dysplasia in metropolitan Brisbane. Arch Ophthalmol 1992;110:525-7.
2. Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol 1995;39:429-50.
3. Majmudar PA, Epstein RJ. Antimetabolites in ocular surface neoplasia. Curr Opin Ophthalmol 1998;9:35-9.
4. Daniell M, Maini R, Tole D. Use of mitomycin C in the treatment of corneal conjunctival intraepithelial neoplasia. Clin Exp Ophthalmol 2002;30:94-8.
5. Khokhar S, Soni A, SinghSethi H, et al. Combined surgery, cryotherapy, and mitomycin-C for recurrent ocular surface squamous neoplasia. Cornea 2002;21:189-91.
6. Wilson MW, Hungerford JL, George SM, et al. Topical mitomycin C for the treatment of conjunctival and corneal epithelial neoplasia with topical mitomycin C. Am J Ophthalmol 1997;124:397-9.
7. Vann RR, Karp CL. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia. Ophthalmology 1999;106:91-7.
8. Kaines A, Malhotra R, Selva D, et al. Conjunctival squamous cell carcinoma with perineural invasion. Arch Ophthalmol, (in press).
9. Sudesh S, Rapuano CJ, Cohen EJ, et al. Surgical management of ocular surface squamous neoplasms: the experience from a cornea center. Cornea 2000;19:278-83.
10. McKelvie Daniell M. Impression cytology following mitomycin C therapy for ocular surface squamous neoplasia. Br J Ophthalmol 2001;85:1115-19.
11. Frucht-Pery J, Rozenman Y. Mitomycin C therapy for corneal intraepitheliol neoplasia. Am J Ophthalmol 1994;117:164-8.
12. Frucht-Pery J, Sugar J, Baum J, et al. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia - a multicenter experience. Ophthalmology 1997;104:2085-93.
13. Grossniklaus HE, Aaberg TM. Mitomycin C treatment of conjunctival intraepithelial neoplasia. Am J Ophthalmol 1997;124:381-2.
14. Heigle TJ, Stulting RD, Palay DA. Treatment of recurrent epithelial neoplasia with topical mitomycin C. Am J Ophthalmol 1997;124:397-9.
15. Kemp EG, Harnett AN, Chatterjee S. Preoperative topical and intraaperative local mitamycin C adjuvant therapy in the management of ocular surface neoplasias. Br J Ophthalmol 2002 Jan;86:31-4.
16. Shields CL, Naseripour M, Shields JA. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. Am J Ophthalmol 2002;133:601-6.